About Egalet
Egalet is a company based in Værløse (Denmark) founded in 1995.. Egalet has raised $70.88 million across 8 funding rounds from investors including Danske Bank, Atlas Venture and Index Ventures. The company has 1 employees as of January 31, 2020. Egalet has completed 1 acquisition, including SPRIX. Egalet offers products and services including Pharmaceutical Products. Egalet operates in a competitive market with competitors including Flexion Therapeutics, Cara Therapeutics, Eliem Therapeutics, Ethypharm and Zogenix, among others.
- Headquarter Værløse, Denmark
- Employees 1 as on 31 Jan, 2020
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Assertio Holdings, Inc.
-
Annual Revenue
$2.01 M-78as on Dec 31, 2024
-
Net Profit
$-21.58 M93as on Dec 31, 2024
-
EBITDA
$-24.48 M90as on Dec 31, 2024
-
Total Equity Funding
$70.88 M (USD)
in 8 rounds
-
Latest Funding Round
$42.16 M (USD), Post-IPO
Feb 19, 2019
-
Investors
Danske Bank
& 8 more
-
Employee Count
1
as on Jan 31, 2020
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Egalet
Egalet offers a comprehensive portfolio of products and services, including Pharmaceutical Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops and distributes prescription drugs for medical treatments
Unlock access to complete
Funding Insights of Egalet
Egalet has successfully raised a total of $70.88M across 8 strategic funding rounds. The most recent funding activity was a Post-IPO round of $42.16 million completed in February 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Post-IPO — $42.2M
-
First Round
First Round
(13 Mar 2006)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2019 | Amount | Post-IPO - Egalet | Valuation |
investors |
|
| Dec, 2017 | Amount | Post-IPO - Egalet | Valuation |
investors |
|
| Jan, 2017 | Amount | Debt – Conventional - Egalet | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Egalet
Egalet has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Danske Bank, Atlas Venture and Index Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology startups and entrepreneurs.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in life science and biotechnology sectors
|
Founded Year | Domain | Location | |
|
Investments are made by Sunstone in early-stage European companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Egalet
Egalet has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include SPRIX. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pain relief nasal spray product is featured on SPRIX website.
|
2003 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Egalet
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Egalet Comparisons
Competitors of Egalet
Egalet operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flexion Therapeutics, Cara Therapeutics, Eliem Therapeutics, Ethypharm and Zogenix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapies for the treatment of musculoskeletal disorders
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for pain relief and inflammatory diseases
|
|
| domain | founded_year | HQ Location |
Develops antibody-based treatments for autoimmune and inflammatory disorders.
|
|
| domain | founded_year | HQ Location |
Therapies for pain and addiction treatment are developed.
|
|
| domain | founded_year | HQ Location |
Drug delivery systems for CNS disorders and pain are developed.
|
|
| domain | founded_year | HQ Location |
Reformulated injectables for chemotherapy side effects and pain are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Egalet
Frequently Asked Questions about Egalet
When was Egalet founded?
Egalet was founded in 1995 and raised its 1st funding round 11 years after it was founded.
Where is Egalet located?
Egalet is headquartered in Værløse, Denmark.
Is Egalet a funded company?
Egalet is a funded company, having raised a total of $70.88M across 8 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $40M, raised on Mar 13, 2006.
How many employees does Egalet have?
As of Jan 31, 2020, the latest employee count at Egalet is 1.
What is the annual revenue of Egalet?
Annual revenue of Egalet is $2.01M as on Dec 31, 2024.
What does Egalet do?
Founded in 1995 and based in Vaerlose, Denmark, the company operates in the pharmaceutical sector. Focus is placed on developing therapeutics for pain management, including a pipeline of clinical-stage opioid-based product candidates. These candidates are engineered to resist abuse through physical and chemical manipulation. The underlying technology is applied across various pharmaceutical classes and supports combination products featuring multiple active ingredients with varied release profiles.
Who are the top competitors of Egalet?
Egalet's top competitors include Flexion Therapeutics, Cara Therapeutics and Trevena.
What products or services does Egalet offer?
Egalet offers Pharmaceutical Products.
How many acquisitions has Egalet made?
Egalet has made 1 acquisition, including SPRIX.
Who are Egalet's investors?
Egalet has 9 investors. Key investors include Danske Bank, Atlas Venture, Index Ventures, Sunstone, and Omega Funds.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.